Steven Bousamra,Stefan Weinert,Juergen Rasch-Menges,P. Douglas Walling,Ajay Thukral,Heino Eikmeier,Birgit Kraeling,Karl Warner,Ulrich Porsch
申请号：
US15887239
公开号：
US20180168448A1
申请日:
2018.02.02
申请国别(地区):
US
年份:
2018
代理人:
摘要：
Embodiments of a testing method for diabetics to optimize their administered insulin dosage comprise collecting sampling sets of biomarker data, each sampling set comprising a sufficient plurality of non-adverse sampling instances and each sampling instance comprising an acceptable biomarker reading at a single point in time recorded upon compliance with adherence criteria, determining a biomarker sampling parameter from each sampling set, comparing the biomarker sampling parameter to a target biomarker range, calculating an insulin adjustment parameter associated with the biomarker sampling parameter if the biomarker sampling parameter falls outside the target biomarker range, adjusting the insulin dosage by the insulin adjustment parameter if the biomarker sampling parameter falls outside the target biomarker range and the insulin dosage does not exceed maximum dosage, and exiting the testing method if the adjusted insulin dosage is optimized. The insulin dosage is optimized when biomarker sampling parameters fall within the target biomarker range.
